October 22, 2024
Baltimore Sun
Brian Witte
Excerpt:
A panel of Maryland lawmakers approved a plan on Tuesday to enable a state board to cap the price that state and local governments pay for certain high-cost prescription drugs for their employees — the latest step taken by a state to try to lower costs for expensive drugs.
The Legislative Policy Committee voted 16-5 to allow the Maryland Prescription Drug Affordability Board to move forward with these cost limits. The board, which was created by the Maryland General Assembly in 2019, is an independent agency with five members. It is supported by a 26-member council that advises it.
“I’m confident that the board and the staff will continue to listen to everyone involved as they implement this action plan,” House Speaker Adrienne A. Jones, a Democrat who co-chairs the committee, said. “We can and must make some prescription drugs more affordable without upending the marketplace.”
Read the full article at TheBaltimoreSun.com
Last modified: October 23, 2024
